CERITINIB IS EFFECTIVE IN ALK-REARRANGED NSCLC

被引：0
|
作者：
不详
机构：
来源：
CANCER DISCOVERY | 2014年 / 4卷 / 06期
关键词：
D O I：
10.1158/2159-8290.CD-RW2016-140
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：632 / 632
页数：1
相关论文
共 50 条
  • [1] CERITINIB EXHIBITS RESPONSES IN PATIENTS WITH ALK-REARRANGED NSCLC
    不详
    CANCER DISCOVERY, 2016, 6 (09) : 943 - 943
  • [2] Looking for a new panacea in ALK-rearranged NSCLC: may be Ceritinib?
    Rolfo, Christian
    Passiglia, Francesco
    Russo, Antonio
    Pauwels, Patrick
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2014, 18 (09) : 983 - 985
  • [3] Overcoming crizotinib resistance in ALK-rearranged NSCLC with the second-generation ALK-inhibitor ceritinib
    Muller, Ittai B.
    De Langen, Adrianus J.
    Honeywell, Richard J.
    Giovannetti, Elisa
    Peters, Godefridus J.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (02) : 147 - 157
  • [4] Treatment and detection of ALK-rearranged NSCLC
    Peters, Solange
    Taron, Miguel
    Bubendorf, Lukas
    Blackhall, Fiona
    Stahel, Rolf
    LUNG CANCER, 2013, 81 (02) : 145 - 154
  • [5] Interpretation of ceritinib clinical trial results and future combination therapy strategies for ALK-rearranged NSCLC
    Blakely, Collin M.
    Riess, Jonathan W.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2019, 19 (12) : 1061 - 1075
  • [6] Pitfalls in Oncology: Osteoblastic Response Mimicking Bone Progression during Ceritinib Treatment in ALK-Rearranged NSCLC
    Gelsomino, Francesco
    Ambrosini, Valentina
    Melotti, Barbara
    Sperandi, Francesca
    Ardizzoni, Andrea
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (08) : E99 - E101
  • [7] Treatment Algorithm for Advanced ALK-Rearranged NSCLC
    Urbanska, Edyta Maria
    Sorensen, Jens Benn
    Santoni-Rugiu, Eric
    JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (09) : E156 - E157
  • [8] Identification of a novel T1151K ALK mutation in a patient with ALK-rearranged NSCLC with prior exposure to crizotinib and ceritinib
    Zhu, Viola W.
    Cui, J. Jean
    Fernandez-Rocha, Maria
    Schrock, Alexa B.
    Ali, Siraj M.
    Ou, Sai-Hong Ignatius
    LUNG CANCER, 2017, 110 : 32 - 34
  • [9] Ceritinib in ALK-Rearranged Non-Small-Cell Lung Cancer
    Shaw, Alice T.
    Kim, Dong-Wan
    Mehra, Ranee
    Tan, Daniel S. W.
    Felip, Enriqueta
    Chow, Laura Q. M.
    Camidge, D. Ross
    Vansteenkiste, Johan
    Sharma, Sunil
    De Pas, Tommaso
    Riely, Gregory J.
    Solomon, Benjamin J.
    Wolf, Juergen
    Thomas, Michael
    Schuler, Martin
    Liu, Geoffrey
    Santoro, Armando
    Lau, Yvonne Y.
    Goldwasser, Meredith
    Boral, Anthony L.
    Engelman, Jeffrey A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (13): : 1189 - 1197
  • [10] Ceritinib in ALK-Rearranged Non-Small-Cell Lung Cancer
    Shen, Liang
    Ji, Hong-Fang
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (26): : 2537 - 2537
12345